Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Main Street. Today, the company is struggling to remain listed on the Nasdaq.
Yeah it was always going to come down to this. You can’t make a lot of money on a business model that involves a selling something only once per customer. Eventually they were going to have to either charge money for data storage or sell what they had.
Yeah it was always going to come down to this. You can’t make a lot of money on a business model that involves a selling something only once per customer. Eventually they were going to have to either charge money for data storage or sell what they had.
There was no “eventually”. The whole point of their business was to sell it. They’ve been selling it since day one.